Discovery Health, South Africa’s largest private health insurance administrator, releases at-scale, real-world analysis of Omicron outbreak based on 211 000 COVID-19 test results in South Africa, including collaboration with the South Africa
Johannesburg, 14 December 2021
Summary:
Vaccine effectiveness:
o The two-dose Pfizer-BioNTech vaccination provides 70% protection against severe complications of COVID-19 requiring hospitalisation, and 33% protection against COVID-19 infection, during the current Omicron wave.
Reinfection risk: For individuals who have had COVID-19 previously, the risk of reinfection with Omicron is